Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Pyrisuccideanol
2. Pyrisuccideanol Dimaleate
3. Pyrisuccideanol Monomaleate
4. Stivane
1. Pyrisuccideanol
2. 33605-94-6
3. Pirisudanol [inn]
4. W618z2smvl
5. Pirisudanol (inn)
6. Pirisudanolum
7. 1-o-[2-(dimethylamino)ethyl] 4-o-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl] Butanedioate
8. Unii-w618z2smvl
9. Pirisudanolum [inn-latin]
10. Einecs 251-591-9
11. Pyrisuccideanol [mi]
12. Schembl49261
13. Pirisudanol [who-dd]
14. Chembl2104859
15. Dtxsid60187301
16. Chebi:135442
17. Db13412
18. D07347
19. Q7198015
20. 2-(dimethylamino)ethyl(5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl)methyl Succinate
| Molecular Weight | 340.37 g/mol |
|---|---|
| Molecular Formula | C16H24N2O6 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | 340.16343649 g/mol |
| Monoisotopic Mass | 340.16343649 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 404 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX08 - Pirisudanol
ABOUT THIS PAGE
A Pirisudanol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pirisudanol, including repackagers and relabelers. The FDA regulates Pirisudanol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pirisudanol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pirisudanol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pirisudanol supplier is an individual or a company that provides Pirisudanol active pharmaceutical ingredient (API) or Pirisudanol finished formulations upon request. The Pirisudanol suppliers may include Pirisudanol API manufacturers, exporters, distributors and traders.
click here to find a list of Pirisudanol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pirisudanol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pirisudanol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pirisudanol GMP manufacturer or Pirisudanol GMP API supplier for your needs.
A Pirisudanol CoA (Certificate of Analysis) is a formal document that attests to Pirisudanol's compliance with Pirisudanol specifications and serves as a tool for batch-level quality control.
Pirisudanol CoA mostly includes findings from lab analyses of a specific batch. For each Pirisudanol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pirisudanol may be tested according to a variety of international standards, such as European Pharmacopoeia (Pirisudanol EP), Pirisudanol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pirisudanol USP).
LOOKING FOR A SUPPLIER?
